Business Wire

Seoul Semiconductor's LED SunLike Improves Eye Health and Sleep Quality, According to Clinical Study

Jaa

Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), a global market leader in LED (light emitting diode) design and manufacturing, announced that a research has shown that its “SunLike” is an optimized LED for human centric lighting that improves eye health and sleep quality.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180712005307/en/

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric light ...

SunLike spectrum that lowered the blue light peak, which is an optimized LED for human centric lighting (Graphic: Business Wire)

The research team of Biomedical Information Laboratory, Seoul National University College of Medicine in Korea, has reported that using SunLike based lighting, the eye discomfort is significantly reduced and the sleep quality is improved compared to conventional LED lighting users.

The researchers conducted experiments on adults including graduate students at Seoul National University, who spend a lot of time studying at their desk indoors. Each participant was instructed to use SunLike desk lamp and conventional LED lamp for 3 hours before bedtime. The team conducted a questionnaire and analyzed the vital signs of participants recorded during sleep.

Subjective evaluation through questionnaires showed a significant decrease in eye fatigue and a marked improvement in sleep quality. The researchers found that improvement of the feeling of not refreshing after a sleep in the following morning was statistically significant.

As a result of analyzing the measured vital sign, the time it takes to fall asleep is 23% faster and the time to break during sleep was also improved by 43%. Therefore, the research team found that sleep efficiency as an indicator of sleep was significantly improved from 88% to 94%.

“We conclude that these effects are due to the stabilization of the autonomic nervous system rhythm, which is manifested by inactivation of sympathetic nerve and activity of parasympathetic nerve by SunLike based lighting,” said the research team of SNU. “Light affects people’s circadian rhythm. In order to improve biorhythm, we can adjust the light according to time zone and use a light source close to sunlight,” said the research team of SNU.

SunLike is an advanced light source that combines the latest optical and compound semiconductor technology of Seoul Semiconductor and *TRI-R technology, a sunlight spectrum reproduction technology, that is a registered trademark by the Toshiba Materials Co., Ltd. It that lowers blue light peak similar to sunlight spectrum contributes to maintaining a stable human circadian rhythms and enhancing the color clarity of objects.

In addition, as a result of analyzing the blue light emitted by the LED ‘SunLike’, it received Eye Safety Certification for level RG-1, the highest level of safety, from Korea Testing & Research Institute last November. This is the level given to a safe light source without any photobiological hazards.

“Since its launch on June 29th, last year in Frankfurt, Germany, with Toshiba Materials Co., Ltd., SunLike has being supplied to global customers in US, Europe, China and Japan that manufacture home lightings, smart desk stands and lamps. It is also currently working on more than 200 projects for SunLike with customers, suppliers and researchers,” said Minsoo Son, marketing vice president of Seoul Semiconductor. “We will prove SunLike is the innovative LED which adds value for human centric lighting by demonstrating differentiated quality and competitiveness to exceed customers’ expectations.”

*TRI-R, supported by Toshiba Materials, finds in the definition “The light closest to the sun for human well-being” as its original concept. The sun light spectrum is developed by the same company and can be reproduced by a white LED light source technology.

About Seoul Semiconductor
Seoul Semiconductor develops and commercializes light emitting diodes (LEDs) for automotive, general illumination, specialty lighting, and backlighting markets. As the fourth-largest LED manufacturer globally, Seoul Semiconductor holds more than 12,000 patents, offers a wide range of technologies, and mass produces innovative LED products such as SunLike – delivering the world’s best light quality in a next-generation LED enabling human-centric lighting optimized for circadian rhythms; WICOP – a simpler structured package-free LED which provides market leading color uniformity and cost savings at the fixture level, providing high lumen density and design flexibility; NanoDriver Series – the world’s smallest 24W DC LED drivers; Acrich, the world's first high-voltage AC-driven LED technology developed in 2005, including all AC LED-related technologies from chip to module and circuit fabrication, as well as multi-junction technology (MJT); and nPola, a new LED product based on GaN-substrate technology that achieves more than ten times the output of conventional LEDs. UCD constitutes a high color gamut display which delivers more than 90% NTSC. To learn more, visit www.seoulsemicon.com.

Contact information

Seoul Semiconductor Co., Ltd.
Korea and Asia
Jeonghee Kim
+82-70-4391-8311
+82-10-4843-6303
jeonghee.kim@seoulsemicon.com
Americas
Andrew Smith
+1 (901) 831-6614
andrew.smith@seoulsemicon.com
China
Vincent Wu
+86-1391-7898226
vincent.wu@seoulsemicon.com
Europe
Marc Juarez
+49 89 450 36 90 31
marc.juarez@seoulsemicon.com
Japan
Kohei Shimooka
+81-80-4668-9710
kohei.shimooka@seoulsemicon.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58Tiedote

Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme